Nicholas D Smith

This inventor holds 59 USPTO granted patents and 35 published patent applications, plus 4 CIPO patents and 23 EPO patents, primarily in Receptor Modulators (CPC class C07D). Top assignees: Aragon Pharmaceuticals, Inc., Genentech, Inc., Merck + Co., Inc.. Active years: 2004-2026.

USPTO Granted Patents = 59 (Patent Applications = 35)

% Patents Active = 69.5

CIPO Patents = 4 (Patent Applications = 20)

EPO Patents = 23 (Patent Applications = 48)

Average Co-Inventor Count = 4.3

ph-index = 11

Forward Citations = 349(Granted Patents)

Forward Citations (Not Self Cited) = 257(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

15 out of 34

Aragon Pharmaceuticals, Inc.

Sloan-Kettering Institute for Cancer Research

patents

6. 6 out of 6

Seragon Pharmaceuticals, Inc.

patents

7. 3 out of 2,405

Merck Sharp + Dohme Corp.

patents

8. 2 out of 4,507

Eli Lilly and Company

patents

9. 2 out of 324

Tanabe Seiyaku Company, Limited

patents

10. 1 out of 263

Mitsubishi Tanabe Pharma Corporation

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Farnesoid X Receptor

Androgen Receptor

Estrogen Receptor

Receptor Agonists

Crystalline Forms

Formulations

Heterocyclic Modulators

Polycyclic Modulators

Azetidine Modulators

Fluorinated Modulators

Indane Modulators

Resistance Determination

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545660 - Crystalline forms of a farnesoid X receptor agonist (2026-02-10),

2. 12491160 - Formulations of a farnesoid X receptor agonist (2025-12-09),

3. 12018008 - Crystalline forms of an androgen receptor modulator (2024-06-25),

4. 11773094 - Farnesoid X receptor agonists and uses thereof (2023-10-03),

5. 11236071 - Farnesoid X receptor agonists and uses thereof (2022-02-01),

6. 11214538 - Farnesoid X receptor agonists and uses thereof (2022-01-04),

7. 11084817 - Farnesoid X receptor agonists and uses thereof (2021-08-10),

8. 10961198 - Farnesoid X receptor agonists and uses thereof (2021-03-30),

9. 10934271 - Crystalline forms of an androgen receptor modulator (2021-03-02),

10. 10927082 - Farnesoid X receptor agonists and uses thereof (2021-02-23),

11. 10766875 - Crystalline forms of an androgen receptor modulator (2020-09-08),

12. 10703712 - Farnesoid X receptor agonists and uses thereof (2020-07-07),

13. 10626081 - Farnesoid X receptor agonists and uses thereof (2020-04-21),

14. 10556882 - Crystalline forms of an androgen receptor modulator (2020-02-11),

15. 10526310 - Crystalline forms of an androgen receptor modulator (2020-01-07),

Title: The Innovative Journey of Nicholas D Smith

Introduction: Nicholas D Smith, a visionary inventor based in San Diego, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Nicholas D Smith's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With over 20 years of experience in the tech industry, Nicholas D Smith has a proven track record of turning innovative ideas into successful products. He has worked for leading tech companies, where he honed his skills in research and development.

Collaborations: Throughout his career, Nicholas D Smith has collaborated with top engineers, designers, and scientists to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Nicholas D Smith's passion for innovation and his dedication to creating solutions that make a positive impact on society have solidified his reputation as a pioneering inventor in the tech world. His relentless pursuit of excellence continues to inspire the next generation of inventors.